Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuli Eldfors

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Computational and Structural Biotechnology Journal|December 26, 2025
Whole exome sequencing and single-cell DNA sequencing for assessment of clonal heterogeneity and evolution in acute myeloid leukemiaSadiksha Adhikari, Samuli Eldfors, Esa Pitkänen, et al.
Experimental Dermatology|April 3, 2014
Novel TBL1XR1, EPHA7 and SLFN12 mutations in a Sezary syndrome patient discovered by whole exome sequencingEmma Andersson, Samuli Eldfors, Henrik Edgren, et al.
Oncotarget|January 4, 2018
Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterationsNoora Porkka, Satu Valo, Taina T Nieminen, et al.
Oncotarget|April 16, 2020
Does breast carcinoma belong to the Lynch syndrome tumor spectrum? - Somatic mutational profiles vs. ovarian and colorectal carcinomasNoora K Porkka, Alisa Olkinuora, Teijo Kuopio, et al.
Cancers|July 15, 2020
Molecular Basis of Mismatch Repair Protein Deficiency in Tumors from Lynch Suspected Cases with Negative Germline Test ResultsAlisa Olkinuora, Annette Gylling, Henrikki Almusa, et al.
BMC Cancer|July 6, 2016
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancerSara Kangaspeska, Susanne Hultsch, Alok Jaiswal, et al.
Blood Advances|January 10, 2024
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemiaSamuli Eldfors, Joseph Saad, Nemo Ikonen, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Sensitivity to ATR-CHK1 pathway inhibition in AML/MDS is enhanced by <i>SRSF2</i> mutations and reduced by RUNX1 lossSamuli Eldfors, Sumit Rai, Vineet Sharma, et al.
International Journal of Cancer|December 22, 2018
Epidemiological, clinical and molecular characterization of Lynch-like syndrome: A population-based studyNoora Porkka, Laura Lahtinen, Maarit Ahtiainen, et al.
Head and Neck Pathology|January 30, 2026
Circulating Tumor HPV DNA Kinetics for Squamous Cell Carcinoma of the Lacrimal Sac Treated with ChemoradiotherapyJonathan J Paly, William C Faquin, Ross D Merkin, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Computational and Structural Biotechnology Journal|December 26, 2025
Whole exome sequencing and single-cell DNA sequencing for assessment of clonal heterogeneity and evolution in acute myeloid leukemiaSadiksha Adhikari, Samuli Eldfors, Esa Pitkänen, et al.
Experimental Dermatology|April 3, 2014
Novel TBL1XR1, EPHA7 and SLFN12 mutations in a Sezary syndrome patient discovered by whole exome sequencingEmma Andersson, Samuli Eldfors, Henrik Edgren, et al.
Oncotarget|January 4, 2018
Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterationsNoora Porkka, Satu Valo, Taina T Nieminen, et al.
Oncotarget|April 16, 2020
Does breast carcinoma belong to the Lynch syndrome tumor spectrum? - Somatic mutational profiles vs. ovarian and colorectal carcinomasNoora K Porkka, Alisa Olkinuora, Teijo Kuopio, et al.
Cancers|July 15, 2020
Molecular Basis of Mismatch Repair Protein Deficiency in Tumors from Lynch Suspected Cases with Negative Germline Test ResultsAlisa Olkinuora, Annette Gylling, Henrikki Almusa, et al.
BMC Cancer|July 6, 2016
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancerSara Kangaspeska, Susanne Hultsch, Alok Jaiswal, et al.
Blood Advances|January 10, 2024
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemiaSamuli Eldfors, Joseph Saad, Nemo Ikonen, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Sensitivity to ATR-CHK1 pathway inhibition in AML/MDS is enhanced by <i>SRSF2</i> mutations and reduced by RUNX1 lossSamuli Eldfors, Sumit Rai, Vineet Sharma, et al.
International Journal of Cancer|December 22, 2018
Epidemiological, clinical and molecular characterization of Lynch-like syndrome: A population-based studyNoora Porkka, Laura Lahtinen, Maarit Ahtiainen, et al.
Head and Neck Pathology|January 30, 2026
Circulating Tumor HPV DNA Kinetics for Squamous Cell Carcinoma of the Lacrimal Sac Treated with ChemoradiotherapyJonathan J Paly, William C Faquin, Ross D Merkin, et al.
Pageof 3